FIGURE 3.
Attenuation of pathologic damage in GVHD target organs treated by berberine (N = 10/group). (A–C) Histology of lung in each group (100×). (D–F) Histology of liver in each group (400×). (G–I) Histology of colon in each group (400×). (J) The pathology score of the lung, liver and colon in three groups using SSS as detailed in Methods section. Data are shown as mean ± SD and were analysed by one‐way ANOVA. * p < 0.05 and ** p < 0.01